1. Home
  2. AERO vs NKTR Comparison

AERO vs NKTR Comparison

Compare AERO & NKTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

AERO

Grupo Aeromexico S.A.B.

HOLD

Current Price

$15.19

Market Cap

2.3B

ML Signal

HOLD

Logo Nektar Therapeutics

NKTR

Nektar Therapeutics

HOLD

Current Price

$68.68

Market Cap

2.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AERO
NKTR
Founded
1934
1990
Country
Mexico
United States
Employees
17068
N/A
Industry
Air Freight/Delivery Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.3B
2.2B
IPO Year
N/A
1996

Fundamental Metrics

Financial Performance
Metric
AERO
NKTR
Price
$15.19
$68.68
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
7
7
Target Price
$28.57
$146.67
AVG Volume (30 Days)
287.8K
1.2M
Earning Date
04-21-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$307,711,000.00
Revenue This Year
$11.85
N/A
Revenue Next Year
$4.57
N/A
P/E Ratio
$7.95
N/A
Revenue Growth
N/A
86.00
52 Week Low
$12.26
$21.02
52 Week High
$23.05
$109.00

Technical Indicators

Market Signals
Indicator
AERO
NKTR
Relative Strength Index (RSI) 36.13 50.64
Support Level $14.46 $64.30
Resistance Level $17.17 $76.78
Average True Range (ATR) 0.76 4.09
MACD -0.23 -0.29
Stochastic Oscillator 12.85 29.42

Price Performance

Historical Comparison
AERO
NKTR

About AERO Grupo Aeromexico S.A.B.

Grupo Aeromexico SAB de CV engages in providing air transport services for passengers, goods, and cargo, as well as loyalty program services, training and management services, franchise systems commercialization, and the management of investment in shares. Its services include passenger and cargo transportation, the Club Premier loyalty program, training, charter services, and other aviation-related activities. The company operates through a single operating segment, air transportation, and its geographical presence includes both domestic and international markets, with the majority of revenue coming from the international market.

About NKTR Nektar Therapeutics

Nektar Therapeutics is a clinical-stage, research-based biopharmaceutical company headquartered in San Francisco, California, and incorporated in Delaware, focused on discovering and developing medicines in the field of immunotherapy. The Company directs its efforts toward creating immunomodulatory agents that selectively induce, amplify, attenuate, or prevent immune responses to achieve desired therapeutic outcomes. Its pipeline of clinical-stage and preclinical-stage immunomodulatory agents targets the treatment of autoimmune diseases, including rezpegaldesleukin, NKTR-0165, NKTR-0166, and NKTR-422, as well as cancer, including NKTR-255.

Share on Social Networks: